Estradiol and progesterone regulate the proliferation of human breast epithelial cells

被引:106
作者
Foidart, JM
Colin, C
Denoo, X
Desreux, J
Béliard, A
Fournier, S
de Lignières, B
机构
[1] Univ Liege, Biol Lab, B-4000 Liege, Belgium
[2] Univ Louvain, Brussels, Belgium
[3] Hop Necker Enfants Malad, Dept Endocrinol & Reprod Med, Paris, France
[4] Labs Besins Iscovesco, Paris, France
关键词
human; in vivo; normal breast; progesterone; estradiol percutaneous administration; steroid concentration; proliferation markers; proliferating cell nuclear antigen; mitotic index; DNA ploidy;
D O I
10.1016/S0015-0282(98)00042-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To study the effects of estradiol and progesterone on the proliferation of normal human breast epithelial cells in vivo. Design: Double-blind randomized study. Setting: Department of gynaecology and of cell biology at a university hospital. Patient(s): Forty postmenopausal women with untreated menopause and documented plasma FSH levels of > 30 mlU/mL and estradiol levels of < 20 pg/mL. Intervention(s): Daily topical application to both breasts or a gel containing a placebo, estradiol, progesterone, or a combination of estradiol and progesterone during the 14 days preceding esthetic boast surgery or excision of a benign lesion. Main Outcome Measure(s): Plasma and breast tissue concentrations of estradiol and progesterone. Epithelial cell cycles were evaluated in normal breast tissue by counting mitoses and performing quantitative proliferating cell nuclear antigen immunolabeling analyses. Result(s): Increasing the estradiol concentration enhanced the number of cycling epithelial cells, whereas increasing the progesterone concentration significantly limited the number of cycling epithelial cells. Conclusion(s): Exposure to progesterone for 14 days reduced the estradiol-induced proliferation of normal breast epithelial cells in vivo. (C) 1998 by American Society for Reproductive Medicine.
引用
收藏
页码:963 / 969
页数:7
相关论文
共 30 条
  • [1] ORAL-CONTRACEPTIVE USE INFLUENCES RESTING BREAST PROLIFERATION
    ANDERSON, TJ
    BATTERSBY, S
    KING, RJB
    MCPHERSON, K
    GOING, JJ
    [J]. HUMAN PATHOLOGY, 1989, 20 (12) : 1139 - 1144
  • [2] BARRAT J, 1990, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V19, P269
  • [3] BOTELLA J, 1989, J PHARMACOL EXP THER, V248, P758
  • [4] BOTELLA J, 1991, J STEROID BIOCH MOL, V50, P41
  • [5] CYCLIN PCNA IS THE AUXILIARY PROTEIN OF DNA POLYMERASE-DELTA
    BRAVO, R
    FRANK, R
    BLUNDELL, PA
    MACDONALDBRAVO, H
    [J]. NATURE, 1987, 326 (6112) : 515 - 517
  • [6] Cappelletti V, 1995, ANTICANCER RES, V15, P2551
  • [7] INFLUENCES OF PERCUTANEOUS ADMINISTRATION OF ESTRADIOL AND PROGESTERONE ON HUMAN BREAST EPITHELIAL-CELL CYCLE IN-VIVO
    CHANG, KJ
    LEE, TTY
    LINARESCRUZ, G
    FOURNIER, S
    DELIGNIERES, B
    [J]. FERTILITY AND STERILITY, 1995, 63 (04) : 785 - 791
  • [8] THE USE OF ESTROGENS AND PROGESTINS AND THE RISK OF BREAST-CANCER IN POSTMENOPAUSAL WOMEN
    COLDITZ, GA
    HANKINSON, SE
    HUNTER, DJ
    WILLETT, WC
    MANSON, JE
    STAMPFER, MJ
    HENNEKENS, C
    ROSNER, B
    SPEIZER, FE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (24) : 1589 - 1593
  • [9] De Boever J, 1983, ENDOCRINOLOGY CYSTIC, P93
  • [10] TOXICOLOGICAL AND PATHOLOGICAL APPLICATIONS OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA), A NOVEL ENDOGENOUS MARKER FOR CELL-PROLIFERATION
    DIETRICH, DR
    [J]. CRITICAL REVIEWS IN TOXICOLOGY, 1993, 23 (01) : 77 - 109